Response Genetics, Inc. (RGDX) is a biotechnology company based in California, USA. The company develops and commercializes molecular diagnostic tests for cancer. Its proprietary tests provide information about the molecular characteristics of tumors, which helps physicians personalize treatment plans for cancer patients. RGDX has developed a number of tests for different types of cancer, including lung, breast, and colon cancer.
In addition to its proprietary tests, RGDX also offers laboratory testing services to biopharmaceutical companies and academic institutions. These services include genomic testing, gene expression analysis, and tissue processing.
RGDX was founded in 1999 and has since grown into a leading provider of molecular diagnostic tests for cancer. The company has partnerships with several major pharmaceutical companies, including Pfizer and AstraZeneca. RGDX is dedicated to improving the lives of cancer patients through the development of innovative diagnostic tests and personalized treatment plans.
Response Genetics, Inc. (RGDX) is a biotechnology company based in California, USA. The company develops and commercializes molecular diagnostic tests for cancer. Its proprietary tests provide information about the molecular characteristics of tumors, which helps physicians personalize treatment plans for cancer patients. RGDX has developed a number of tests for different types of cancer, including lung, breast, and colon cancer.